Jazz Pharmaceuticals JAZZ Other — Revenue from Contract with Customer, Excluding Assessed Tax
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax?
- Jazz Pharmaceuticals (JAZZ) reported other — revenue from contract with customer, excluding assessed tax of $2.7M in Q1 2026.
- How has Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax changed year-over-year?
- Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax decreased by 73.8% year-over-year, from $10.3M to $2.7M.
- What is the long-term trend for Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax has grown at a 19.8% compound annual growth rate (CAGR), from $9.8M to $20.16M.
- What does other — revenue from contract with customer, excluding assessed tax mean?
- The total sales revenue generated by the company's 'Other' product category after excluding taxes.
- How do you interpret other — revenue from contract with customer, excluding assessed tax?
- Rising revenue indicates successful market penetration or growth of secondary product lines, whereas declining revenue may signal product maturity, competitive pressure, or strategic de-prioritization.
- How does other — revenue from contract with customer, excluding assessed tax compare across companies?
- Most pharmaceutical companies report revenue by product or therapeutic area, making this comparable to 'Other' or 'Miscellaneous' product revenue lines in peer financial statements.